NCT03355274

Brief Summary

The measurement of the transcutaneous oxygen partial pressure (TCPO2) at exercise is, to our knowledge, the only method to estimate during the exercise the importance of ischemia segment of limb by segment of limb bilaterally and carry on. The diagnosis of thoracic outlet syndrome causing remains difficult and dependent operator in ultrasound because of the risk of false positive (loss of signal) or false negative (insufficient effort, inappropriate movement). Our main hypothesis is the existence of significant measurable ischemia in the forearm by transcutaneous oximetry during the maneuvering of the "candlestick". In the event of failure of this maneuver, the other maneuvers such as those of Wright, Roos, Tinel and Adson will be realized. In this study we want to evaluate the possibility of using dynamic transcutaneous Oximetry as a tool for evaluating ischemia in case of suspicion of thoracic outlet syndrome causing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
222

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 20, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 28, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

March 26, 2018

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 4, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 4, 2024

Completed
Last Updated

March 17, 2025

Status Verified

March 1, 2025

Enrollment Period

5.8 years

First QC Date

November 20, 2017

Last Update Submit

March 14, 2025

Conditions

Keywords

Transcutaneous Oximetry

Outcome Measures

Primary Outcomes (1)

  • Decrease from Rest of Oxygen Pressure (DROP) during manoeuvers in patients and controls.

    Difference in DROP observed in the symptomatic arm of patients with suspected thoracic outlet syndrome compared to the dominant arm in controls

    inclusion

Secondary Outcomes (3)

  • Presence of stenosis or occlusion on angiography

    24 months

  • POsitive and negative DROP results

    24 months

  • Angle of appearance of the compression observed on PPG

    24 months

Study Arms (2)

Patients

EXPERIMENTAL

Patients suspected of thoracic outlet syndrome Transcutaneous oximetry during upper arm manoeuvers

Diagnostic Test: Transcutaneous OximetryDiagnostic Test: PhotopletysmographyOther: Questionnaires of Quality of Life (QoL)

controls

SHAM COMPARATOR

healthy asymptomatic subjects Transcutaneous oximetry during upper arm manoeuvers

Diagnostic Test: Transcutaneous OximetryDiagnostic Test: PhotopletysmographyOther: Questionnaires of Quality of Life (QoL)

Interventions

The examination of transcutaneous Oximetry dynamic measurement with palmar face of both forearms during two consecutive maneuvers known as the "candlestick" (hands up).

Patientscontrols
PhotopletysmographyDIAGNOSTIC_TEST

Maneuvers are repeted with the photoplestysmography sensors and in front of a Kinect camera.

Patientscontrols

Each subject complete 2 QoL questionnaires : Sf-12 (Short Form 12) and DASH (Disabilities of the Arm, Shoulder and Hand).

Patientscontrols

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • subjects referred for investigation of thoracic outlet syndrome causing
  • Affiliation to the French National healthcare system
  • French speaking patients
  • Ability to stand still for half a minute

You may not qualify if:

  • pregnancy
  • inability to understand the study goal
  • Patients protected by decision of law

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UH Angers

Angers, 49100, France

Location

Related Publications (1)

  • Hersant J, Ramondou P, Guilleron C, Picquet J, Henni S, Abraham P. A pilot study of forearm microvascular impairment and pain while using a telephone. Microvasc Res. 2020 May;129:103963. doi: 10.1016/j.mvr.2019.103963. Epub 2019 Nov 29.

MeSH Terms

Conditions

Thoracic Outlet Syndrome

Interventions

Blood Gas Monitoring, Transcutaneous

Condition Hierarchy (Ancestors)

Nerve Compression SyndromesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

OximetryBlood Gas AnalysisBlood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisHeart Function TestsDiagnostic Techniques, CardiovascularRespiratory Function TestsDiagnostic Techniques, Respiratory SystemInvestigative Techniques

Study Officials

  • Samir MD HENNI, PhD

    UH Angers

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Patients with thoracic outlet syndrom (patients) Healthy asymptomatic patients (controls)
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 20, 2017

First Posted

November 28, 2017

Study Start

March 26, 2018

Primary Completion

January 4, 2024

Study Completion

January 4, 2024

Last Updated

March 17, 2025

Record last verified: 2025-03

Locations